세계의 유전자 합성 시장 - 예측(2025-2030년)

The Gene Synthesis Market will surge from USD 2.304 billion in 2025 to USD 5.234 billion by 2030, fueled by a 17.83% CAGR.

Gene synthesis entails the chemical, base-by-base in vitro creation of double-stranded DNA sequences encoding genes, serving as a vital tool in vaccine development, gene therapy, molecular engineering, and recombinant DNA production. Recent advancements enable the integration of modified nucleotides or novel base pairs, potentially expanding the genetic code.

The gene synthesis market is propelled by increased investments in genomics and next-generation sequencing research and development. Growing government funding and interest in genomics further drive market expansion. However, high costs and technical complexities of gene synthesis methods present significant challenges. A shortage of skilled professionals proficient in these techniques may also hinder market growth during the forecast period.

This research examines current market trends in demand, supply, and sales, alongside recent developments. It provides an in-depth analysis of key drivers, restraints, and opportunities shaping the market. The study details industry trends, policies, and regulations across geographical regions, offering stakeholders a comprehensive understanding of the regulatory framework and critical factors influencing the market.

Competitive intelligence identifies major industry players and their revenue contributions, derived from extensive secondary research. Sources include industry association studies, analyst reports, investor presentations, press releases, and journals.

Market size for the gene synthesis sector and its key segments was determined using both bottom-up and top-down approaches. Values were validated with primary inputs from stakeholders in the global gene synthesis value chain. Comprehensive market engineering integrated data from diverse sources and proprietary datasets, employing data triangulation for market breakdown and forecasting.

Market insights are presented through analytical narratives, charts, and graphics, enabling clients to efficiently grasp the global gene synthesis market dynamics. Key players profiled include Evonetix, Genewiz, and ATUM, among others.

This report equips industry experts with critical insights into market trends, regulatory landscapes, and competitive dynamics. It highlights opportunities in genomics-driven innovations while addressing challenges such as cost, complexity, and talent scarcity. The rigorous methodology, blending primary and secondary data, ensures reliable findings, enabling stakeholders to navigate investment priorities, regulatory complexities, and competitive pressures in a rapidly evolving field driven by technological advancements and expanding applications.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Product Type & Service Type

• Gene Synthesis Products
• Gene Synthesis Services
• Software & Bioinformatics Tools

By Technology

• Solid-Phase Synthesis
• Chip-Based Synthesis
• PCR-Based Enzyme Synthesis
• Others

By Gene Type

• Standard Gene Synthesis
• Complex Gene Synthesis
• Codon-Optimized Genes
• Others

By Application

• Synthetic Biology
• Genetic Engineering
• Diagnostics & Therapeutics Development
• Protein Engineering
• Industrial Biotechnology
• Others

By End-User

• Pharmaceuticals and Biopharmaceutical Companies
• Contract Research Organisations (CROs)
• Academic & Research Institutes
• Diagnostics Laboratories
• Others

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Italy
• Others
• Middle East & Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GENE SYNTHESIS MARKET BY PRODUCT TYPE & SERVICE TYPE

• 5.1. Introduction
• 5.2. Gene Synthesis Products
• 5.3. Gene Synthesis Services
• 5.4. Software & Bioinformatics Tools

6. GENE SYNTHESIS MARKET BY TECHNOLOGY

• 6.1. Introduction
• 6.2. Solid-Phase Synthesis
• 6.3. Chip-Based Synthesis
• 6.4. PCR-Based Enzyme Synthesis
• 6.5. Others

7. GENE SYNTHESIS MARKET GENE TYPE

• 7.1. Introduction
• 7.2. Standard Gene Synthesis
• 7.3. Complex Gene Synthesis
• 7.4. Codon-Optimized Genes
• 7.5. Others

8. GENE SYNTHESIS MARKET BY APPLICATION

• 8.1. Introduction
• 8.2. Synthetic Biology
• 8.3. Genetic Engineering
• 8.4. Diagnostics & Therapeutics Development
• 8.5. Protein Engineering
• 8.6. Industrial Biotechnology
• 8.7. Others

9. GENE SYNTHESIS MARKET BY END-USER

• 9.1. Introduction
• 9.2. Pharmaceuticals and Biopharmaceutical Companies
• 9.3. Contract Research Organisations (CROs)
• 9.4. Academic & Research Institutes
• 9.5. Diagnostics Laboratories
• 9.6. Others

10. GENE SYNTHESIS MARKET BY GEOGRAPHY

• 10.1. Introduction
• 10.2. North America
  • 10.2.1. By Product Type & Service Type
  • 10.2.2. By Technology
  • 10.2.3. By Gene Type
  • 10.2.4. By Application
  • 10.2.5. By End-User
  • 10.2.6. By Country
    • 10.2.6.1. United States
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. South America
  • 10.3.1. By Product Type & Service Type
  • 10.3.2. By Technology
  • 10.3.3. By Gene Type
  • 10.3.4. By Application
  • 10.3.5. By End-User
  • 10.3.6. By Country
    • 10.3.6.1. Brazil
    • 10.3.6.2. Argentina
    • 10.3.6.3. Others
• 10.4. Europe
  • 10.4.1. By Product Type & Service Type
  • 10.4.2. By Technology
  • 10.4.3. By Gene Type
  • 10.4.4. By Application
  • 10.4.5. By End-User
  • 10.4.6. By Country
    • 10.4.6.1. United Kingdom
    • 10.4.6.2. Germany
    • 10.4.6.3. France
    • 10.4.6.4. Italy
    • 10.4.6.5. Others
• 10.5. Middle East & Africa
  • 10.5.1. By Product Type & Service Type
  • 10.5.2. By Technology
  • 10.5.3. By Gene Type
  • 10.5.4. By Application
  • 10.5.5. By End-User
  • 10.5.6. By Country
    • 10.5.6.1. Saudi Arabia
    • 10.5.6.2. UAE
    • 10.5.6.3. Others
• 10.6. Asia Pacific
  • 10.6.1. By Product Type & Service Type
  • 10.6.2. By Technology
  • 10.6.3. By Gene Type
  • 10.6.4. By Application
  • 10.6.5. By End-User
  • 10.6.6. By Country
    • 10.6.6.1. Japan
    • 10.6.6.2. China
    • 10.6.6.3. India
    • 10.6.6.4. South Korea
    • 10.6.6.5. Taiwan
    • 10.6.6.6. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 11.1. Major Players and Strategy Analysis
• 11.2. Market Share Analysis
• 11.3. Mergers, Acquisitions, Agreements, and Collaborations
• 11.4. Competitive Dashboard

12. COMPANY PROFILES

• 12.1. Thermo Fisher Scientific Inc.
• 12.2. Azenta Life Sciences
• 12.3. GenScript Biotech Corporation
• 12.4. Eurofins Genomics LLC
• 12.5. ATUM
• 12.6. Synbio Technologies LLC
• 12.7. Epoch Life Science Inc.
• 12.8. GCC Biotech Pvt. Ltd.
• 12.9. Twist Bioscience Corporation
• 12.10. Integrated DNA Technologies, Inc.
• 12.11. OriGene Technologies, Inc.
• 12.12. Biomatik

13. RESEARCH METHODOLOGY